Chitosan Nanoparticulate System Loaded with Cannabidiol: A Topical Formulation for Potential Alopecia Management

This study explores an innovative topical formulation to treat alopecia by encapsulating cannabidiol (CBD) in chitosan nanoparticles. CBD, widely known for its anti-inflammatory, antioxidant, and endocannabinoid-modulating effects, shows significant potential for treating alopecia, a condition characterized by hair loss influenced by genetic, hormonal, or environmental factors. However, its low water solubility presents a significant challenge for topical applications. To address this issue, chitosan nanoparticles were synthesized using chitosan of reduced molecular mass (270 kDa) with an acetylation level of 12%, β-glycerophosphate as a crosslinking agent, and 1% glycerol to improve CBD encapsulation efficiency. Physicochemical characterization using scanning electron microscopy (SEM), zeta potential measurement, and Fourier transform infrared spectroscopy (FTIR) revealed that the β-glycerophosphate concentration impacted nanoparticle size and the electrostatic interactions between chitosan’s primary amines and phosphate groups of β-glycerophosphate. Among the tested concentrations (0.05, 0.1, 0.2, and 0.25 mol/L), 0.20 mol/L produced the smallest nanoparticles (390 nm), which were further optimized to encapsulate CBD, reaching a particle size of 227 nm. This optimized formulation may improve the solubility of CBD and enable targeted and sustained delivery to hair follicles. These findings highlight chitosan nanoparticles as a cutting-edge and scalable platform for transdermal delivery of hydrophobic bioactive compounds, presenting a promising approach for the effective management of alopecia.